A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Generalized Anxiety Disorder scale (GAD-2) for people with suspected anxiety disorders:- In people with suspected anxiety disorders, what is the clinical utility of using the GAD-2 compared with ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...

Most people worry, but for those with generalized anxiety disorder, worries are chronic and lead to symptoms like exhaustion, nausea, and trouble sleeping. The first step toward treatment is ...

In primary care settings, generalized anxiety is the most common type of psychiatric disorder (>50%), followed by specific phobias together, they account for 90% of late-life anxiety disorders.